Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2017 2
2018 6
2019 9
2020 7
2021 5
2022 3
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Segesterone Acetate.
[No authors listed] [No authors listed] 2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30371999 Free Books & Documents. Review.
Nestorone (segesterone acetate) effects on neuroregeneration.
Sitruk-Ware R, Sussman H, Brinton R, Schumacher M, Singer P, Kumar N, De Nicola AF, El-Etr M, Guennoun R, V Borlongan C. Sitruk-Ware R, et al. Front Neuroendocrinol. 2024 Apr;73:101136. doi: 10.1016/j.yfrne.2024.101136. Epub 2024 Apr 25. Front Neuroendocrinol. 2024. PMID: 38670433 Review.
Nestorone (segesterone acetate) is a progestin with a chemical structure closely related to progesterone with high affinity and selectivity for the progesterone receptor without significant interaction with other steroid receptors. ...
Nestorone (segesterone acetate) is a progestin with a chemical structure closely related to progesterone with high affinity an …
Emerging approaches to male contraception.
Thirumalai A, Amory JK. Thirumalai A, et al. Fertil Steril. 2021 Jun;115(6):1369-1376. doi: 10.1016/j.fertnstert.2021.03.047. Epub 2021 Apr 27. Fertil Steril. 2021. PMID: 33931201 Free PMC article. Review.
Additionally, combinations of a topical testosterone gel combined with a gel containing segesterone acetate, a potent progestin, have shown promise in clinical trials recently. ...
Additionally, combinations of a topical testosterone gel combined with a gel containing segesterone acetate, a potent progesti …
A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year.
Micks EA, Jensen JT. Micks EA, et al. Expert Opin Drug Deliv. 2020 Jun;17(6):743-752. doi: 10.1080/17425247.2020.1764529. Epub 2020 May 15. Expert Opin Drug Deliv. 2020. PMID: 32410464 Review.
INTRODUCTION: The segesterone acetate and ethinyl estradiol contraceptive vaginal ring (SA/EE CVR) was FDA-approved in August 2018 and is now available in the U.S. ...
INTRODUCTION: The segesterone acetate and ethinyl estradiol contraceptive vaginal ring (SA/EE CVR) was FDA-approved in August …
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.
Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, Thomas M, Barnhart KT, Creasy G, Sussman H, Alami M, Burke AE, Weisberg E, Fraser I, Miranda MJ, Gilliam M, Liu J, Carr BR, Plagianos M, Roberts K, Blithe D. Gemzell-Danielsson K, et al. Contraception. 2019 Jun;99(6):323-328. doi: 10.1016/j.contraception.2019.02.001. Epub 2019 Mar 1. Contraception. 2019. PMID: 30831102 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate safety outcomes from clinical studies of a 12-month contraceptive vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and ethinyl estradiol (EE) 13 mcg daily. ...
OBJECTIVES: To evaluate safety outcomes from clinical studies of a 12-month contraceptive vaginal system (CVS) releasing an average of se …
Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method.
Nelson AL. Nelson AL. Expert Rev Clin Pharmacol. 2019 Oct;12(10):953-963. doi: 10.1080/17512433.2019.1669448. Epub 2019 Oct 1. Expert Rev Clin Pharmacol. 2019. PMID: 31526281 Review.
Finally, subanalyses from the clinical trials are presented to guide clinicians in counseling potential users. Expert Opinion: This CVR introduces a new progestin - segesterone acetate (SA) - that has no androgenic or estrogenic action in vitro or in vivo, but has t …
Finally, subanalyses from the clinical trials are presented to guide clinicians in counseling potential users. Expert Opinion: This CVR intr …
Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system.
Liu JH, Plagianos M, Archer DF, Simon JA, Kaunitz AM, Graham S, Bernick B, Mirkin S. Liu JH, et al. Contraception. 2021 Sep;104(3):229-234. doi: 10.1016/j.contraception.2021.03.024. Epub 2021 Mar 27. Contraception. 2021. PMID: 33785318 Free article.
IMPLICATIONS: Based on statistical modeling, the long-term, user-controlled contraceptive vaginal system containing segesterone acetate and ethinyl estradiol may have the potential to provide effective pregnancy prevention if used continuously (without removal) for …
IMPLICATIONS: Based on statistical modeling, the long-term, user-controlled contraceptive vaginal system containing segesterone ac …
The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring.
Thompson RL, Hu J, Custodio P, Dart C, Jensen JT. Thompson RL, et al. Contraception. 2022 Apr;108:61-64. doi: 10.1016/j.contraception.2021.12.004. Epub 2021 Dec 28. Contraception. 2022. PMID: 34971614 Clinical Trial.
OBJECTIVES: To determine the incidence of out-of-range segesterone acetate (NES) concentrations in participants of a pharmacokinetic/pharmacodynamic trial of a continuous use contraceptive vaginal ring (CVR) releasing NES and estradiol (E2). ...
OBJECTIVES: To determine the incidence of out-of-range segesterone acetate (NES) concentrations in participants of a pharmacok …
Polymorphism characterization of segesterone acetate: A comprehensive study using XRPD, FT-IR and Raman spectroscopy.
Aragon FFH, Haeck CM, Morais PC, Variano B. Aragon FFH, et al. Int J Pharm. 2021 Mar 1;596:120234. doi: 10.1016/j.ijpharm.2021.120234. Epub 2021 Jan 21. Int J Pharm. 2021. PMID: 33484926
Segesterone acetate (SA) is a promising and recently approved drug substance used as a contraceptive. ...
Segesterone acetate (SA) is a promising and recently approved drug substance used as a contraceptive. ...
40 results